{"id":13567,"date":"2011-01-28T07:30:00","date_gmt":"2011-01-28T06:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/usa-tagli-del-personale-del-2-in-abbott\/"},"modified":"2011-01-28T07:30:00","modified_gmt":"2011-01-28T06:30:00","slug":"usa-tagli-del-personale-del-2-in-abbott","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/usa-tagli-del-personale-del-2-in-abbott\/","title":{"rendered":"Use: 2% personnel cuts in Abbott"},"content":{"rendered":"<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal\"><font size=\"3\"><font face=\"Calibri\"><\/font><\/font><\/strong><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\"><font face=\"Calibri\">Abbott will cut approximately 1,900 jobs, equal to 2% of employees. The layoffs will mainly concern the commercial and manufacturing sector in the USA. The company explains that this measure was necessary to reduce costs and address the changes currently taking place in the US healthcare industry. This first round of layoffs is part of the company&#039;s restructuring program which intends to cut 3,000 jobs, equivalent to 3% of its workforce, by 2012 following the purchase of Solvay&#039;s pharmaceutical operations.<\/p>\n<p><\/font><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><span style=\"mso-ansi-language: EN-US\" lang=\"EN-US\"><font size=\"3\"><font face=\"Calibri\">(The Wall Street Journal online \u2013 26\/01\/2011 , The Wall Street Journal Europe Pag.35 \u2013 27\/01\/2011 , The Financial Times Pag.16 \u2013 27\/01\/2011) <img loading=\"lazy\" decoding=\"async\" style=\"width: 96px; height: 22px\" id=\"rg_hi\" class=\"rg_hi\" alt=\"\" width=\"96\" height=\"22\" data-height=\"22\" data-width=\"96\" src=\"http:\/\/t0.gstatic.com\/images?q=tbn:ANd9GcTJaC-gsJDFZ-vsu4cUPK6qBiBGPpi10TXMjpkZKAeQNqkPrdVb\" \/><\/p>\n<p><\/font><\/font><\/span><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><strong style=\"mso-bidi-font-weight: normal\"><span style=\"mso-ansi-language: EN-US\" lang=\"EN-US\"><font size=\"3\"><font face=\"Calibri\">Abbott&#039;s 2010 4th Quarter Results<\/p>\n<p><\/font><\/font><\/span><\/strong><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\"><font face=\"Calibri\">Q4 2010 Abbott reported earnings of $1.4 billion compared to $1.5 billion in 2009. Sales increased by 13% to $9.97 billion, pharmaceuticals by 23% to $5.9 billion bln. The diagnostics sector grew 4.1% to $1 billion in sales and the nutritional sector remained unchanged at $1.4 billion.<\/font><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\"><font face=\"Calibri\"><\/p>\n<p><\/font><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><span style=\"mso-ansi-language: EN-US\" lang=\"EN-US\"><font size=\"3\"><font face=\"Calibri\">(The Wall Street Journal online \u2013 26\/01\/2011 , The Wall Street Journal Europe Pag.35 \u2013 27\/01\/2011 , The Financial Times Pag.16 \u2013 27\/01\/2011) <img loading=\"lazy\" decoding=\"async\" style=\"width: 96px; height: 22px\" id=\"rg_hi\" class=\"rg_hi\" alt=\"\" width=\"96\" height=\"22\" data-height=\"22\" data-width=\"96\" src=\"http:\/\/t0.gstatic.com\/images?q=tbn:ANd9GcTJaC-gsJDFZ-vsu4cUPK6qBiBGPpi10TXMjpkZKAeQNqkPrdVb\" \/><\/font><\/font><\/span><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><span style=\"mso-ansi-language: EN-US\" lang=\"EN-US\"><font size=\"3\"><font face=\"Calibri\"><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"width: 351px; height: 144px\" id=\"rg_hi\" class=\"rg_hi\" alt=\"\" width=\"351\" height=\"144\" data-height=\"144\" data-width=\"351\" src=\"http:\/\/t3.gstatic.com\/images?q=tbn:ANd9GcQVqywUT91QPgHHef2NuVWsXkWtHK5HEUV7TB7wMM5FQSWoiVfSYA\" \/><\/p>\n<p><\/font><\/font><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Abbott taglier&agrave; circa 1.900 posti di lavoro, pari al 2% dei dipendenti. I licenziamenti riguarderanno soprattutto il settore commerciale e produttivo in Usa. L&#8217;azienda spiega che questa misura si &egrave; resa necessaria per ridurre i costi e affrontare i cambiamenti attualmente in atto nell&#8217;industria dell&#8217;healthcare statunitense. Questa prima tranche di licenziamenti fa parte del programma &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-13567","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=13567"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13567\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=13567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=13567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=13567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}